These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Quantification of RNA editing of the serotonin 2C receptor (5-HT(₂C)R) ex vivo. Lanfranco MF; Anastasio NC; Seitz PK; Cunningham KA Methods Enzymol; 2010; 485():311-28. PubMed ID: 21050925 [TBL] [Abstract][Full Text] [Related]
9. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. Price RD; Weiner DM; Chang MS; Sanders-Bush E J Biol Chem; 2001 Nov; 276(48):44663-8. PubMed ID: 11572865 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829 [TBL] [Abstract][Full Text] [Related]
11. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Sodhi MS; Burnet PW; Makoff AJ; Kerwin RW; Harrison PJ Mol Psychiatry; 2001 Jul; 6(4):373-9. PubMed ID: 11443520 [TBL] [Abstract][Full Text] [Related]
12. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. Niswender CM; Copeland SC; Herrick-Davis K; Emeson RB; Sanders-Bush E J Biol Chem; 1999 Apr; 274(14):9472-8. PubMed ID: 10092629 [TBL] [Abstract][Full Text] [Related]
13. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of agonist binding on human 5-HT2C receptor isoforms. Quirk K; Lawrence A; Jones J; Misra A; Harvey V; Lamb H; Revell D; Porter RH; Knight AR Eur J Pharmacol; 2001 May; 419(2-3):107-12. PubMed ID: 11426831 [TBL] [Abstract][Full Text] [Related]
15. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. Wang Q; O'Brien PJ; Chen CX; Cho DS; Murray JM; Nishikura K J Neurochem; 2000 Mar; 74(3):1290-300. PubMed ID: 10693963 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of RNA editing events within the 5-HT2C receptor. Niswender CM; Sanders-Bush E; Emeson RB Ann N Y Acad Sci; 1998 Dec; 861():38-48. PubMed ID: 9928237 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor. Herrick-Davis K; Grinde E; Gauthier C; Teitler M Ann N Y Acad Sci; 1998 Dec; 861():140-5. PubMed ID: 9928251 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms. Fentress HM; Grinde E; Mazurkiewicz JE; Backstrom JR; Herrick-Davis K; Sanders-Bush E Pharmacogenomics J; 2005; 5(4):244-54. PubMed ID: 15912142 [TBL] [Abstract][Full Text] [Related]
19. RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Price RD; Sanders-Bush E Mol Pharmacol; 2000 Oct; 58(4):859-62. PubMed ID: 10999958 [TBL] [Abstract][Full Text] [Related]
20. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]